High expression of transient potential receptor C6 correlated with poor prognosis in patients with esophageal squamous cell carcinoma (Q39149899)

9 September 2017

High expression of transient potential receptor C6 correlated with poor prognosis in patients with esophageal squamous cell carcinoma (English)

1 reference

esophageal squamous cell carcinoma

9 September 2017

1 reference

5

Hong Yang

1 reference

9 September 2017

6

Kong-Jia Luo

1 reference

9 September 2017

12

Jian Hua Fu

1 reference

9 September 2017

Shui-Shen Zhang

1

1 reference

9 September 2017

Jing Wen

2

1 reference

9 September 2017

Fu Yang

3

1 reference

9 September 2017

Xiao-Li Cai

4

1 reference

9 September 2017

Qian Wen Liu

7

1 reference

9 September 2017

Rong-Gui Hu

8

1 reference

9 September 2017

Xuan Xie

9

1 reference

9 September 2017

Qing-Yuan Huang

10

1 reference

9 September 2017

Jun Ying Chen

11

1 reference

9 September 2017

Yi Hu

13

1 reference

9 September 2017

18 May 2013

1 reference

9 September 2017

1 reference

9 September 2017

30

1 reference

9 September 2017

3

1 reference

9 September 2017

607

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-013-0607-7

9 September 2017

0 references

cites work

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

The TRP ion channel family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

21 January 2018

Oncogenic TRP channels

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Blockade of TRPC6 channels induced G2/M phase arrest and suppressed growth in human gastric cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Expression of TRPC6 in benign and malignant human prostate tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Critical role of TRPC6 channels in VEGF-mediated angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

VEGF-mediated elevated intracellular calcium and angiogenesis in human microvascular endothelial cells in vitro are inhibited by dominant negative TRPC6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Expression of TRPC6 channels in human epithelial breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Differential role of transient receptor potential channels in Ca2+ entry and proliferation of prostate cancer epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Calcium signalling: dynamics, homeostasis and remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Targeting TRPC6 channels in oesophageal carcinoma growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

CaT1 expression correlates with tumor grade in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0607-7

Taxol: a novel radiation sensitizer

21 January 2018

1 reference

12 December 2020

Expression of transient receptor potential channel 6 in cervical cancer

1 reference

12 December 2020

7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction

1 reference

12 December 2020

1 reference

12 December 2020

Analysis of the esophageal cancer mortality in 2004 - 2005 and its trends during last 30 years in China

1 reference

12 December 2020

10.1007/S12032-013-0607-7

Identifiers

DOI

1 reference

9 September 2017

1 reference